INO Competitors
Inovio Pharmaceuticals, Inc.
$1.05
+$0.06(+6.49%)
34
Overall
60
Value
10
Tech
34
Quality
Market Cap
$101.95M
Volume
1.11M
52W Range
$0.56 - $2.72
Target Price
$3.17
INO competitors: PFE, JNJ, ARWR, NVS, MRK. Inovio Pharmaceuticals, Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
INO Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| PFE Pfizer Inc. | $29.21 | $166.49B | $2.96 | 5.89% | 70 |
| JNJ Johnson & Johnson | $253.91 | $599.12B | $11.09 | 2.08% | 56 |
| ARWR Arrowhead Pharmaceuticals, Inc. | $58.37 | $8.25B | $-3.62 | - | 33 |
| NVS Novartis AG | $146.88 | $280.27B | $8.89 | 3.25% | 53 |
| MRK Merck & Co., Inc. | $147.37 | $350.29B | $2.66 | 2.31% | 67 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | INO | $1.05 | +6.5% | 1.11M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Inovio Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW